# Connecticut Innovations' Biotech Investments: 33 Startups in Its Portfolio (2026)

> The 33 Biotech startups Connecticut Innovations has backed, by stage: $1.0B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/connecticut-innovations-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Stage not reported

15

- [Biohaven Pharmaceutical](https://millionrounds.com/company/biohaven-pharmaceutical)
- [Arvinas](https://millionrounds.com/company/arvinas)
- [Inbox Health](https://millionrounds.com/company/inbox-health)
- [Thetis Pharmaceuticals](https://millionrounds.com/company/thetis-pharmaceuticals)
- [Artizan Biosciences](https://millionrounds.com/company/artizan-biosciences)
- [BEKHealth](https://millionrounds.com/company/bekhealth)
- [OncoSynergy](https://millionrounds.com/company/oncosynergy)
- [ReNetX Bio](https://millionrounds.com/company/renetx-bio)
- [Intus Bio](https://millionrounds.com/company/intus-bio)
- [Enrich Therapeutics](https://millionrounds.com/company/enrich-therapeutics)
- [*AT* Affinimark Technologies](https://millionrounds.com/company/affinimark-technologies)
- [*B* Bactana](https://millionrounds.com/company/bactana)
- [*AT* Axerion Therapeutics](https://millionrounds.com/company/axerion-therapeutics)
- [*FP* FMP Products](https://millionrounds.com/company/fmp-products)
- [Omnicyte](https://millionrounds.com/company/omnicyte)

## Series A

8

- [Azitra](https://millionrounds.com/company/azitra)
- [Rallybio](https://millionrounds.com/company/rallybio)
- [Alphina Therapeutics](https://millionrounds.com/company/alphina-therapeutics)
- [OOVA](https://millionrounds.com/company/oova)
- [Ancera](https://millionrounds.com/company/ancera)
- [Diameter Health](https://millionrounds.com/company/diameter-health)
- [*TB* Tangen Biosciences](https://millionrounds.com/company/tangen-biosciences)
- [Affomix Corporation](https://millionrounds.com/company/affomix-corporation)

## Series B

7

- [*HT* Halda Therapeutics](https://millionrounds.com/company/halda-therapeutics)
- [Normunity](https://millionrounds.com/company/normunity)
- [Allyx Therapeutics](https://millionrounds.com/company/allyx-therapeutics)
- [Cybrexa Therapeutics](https://millionrounds.com/company/cybrexa-therapeutics)
- [Simcha Therapeutics](https://millionrounds.com/company/simcha-therapeutics)
- [Bioarray Genetics](https://millionrounds.com/company/bioarray-genetics)
- [Precipio Diagnostics](https://millionrounds.com/company/precipio-diagnostics)

## Pre-seed and seed

3

- [Revalia Bio](https://millionrounds.com/company/revalia-bio)
- [*MB* Modifi Bio](https://millionrounds.com/company/modifi-bio)
- [Pattern Genomics](https://millionrounds.com/company/pattern-genomics)

## Segment by segment

### Stage not reported

15 startups · $477M raised

- [**Biohaven Pharmaceutical**](https://millionrounds.com/company/biohaven-pharmaceutical) Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases. United States $280M
- [**Arvinas**](https://millionrounds.com/company/arvinas) Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics. United States $111M
- [**Inbox Health**](https://millionrounds.com/company/inbox-health) Inbox Health is a healthcare technology company based in New Haven, Connecticut, founded in 2014. United States $29M
- [**Thetis Pharmaceuticals**](https://millionrounds.com/company/thetis-pharmaceuticals) Thetis Pharmaceuticals is a biopharmaceutical company. United States $16M
- [**Artizan Biosciences**](https://millionrounds.com/company/artizan-biosciences) Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota. United States $14M
- [**BEKHealth**](https://millionrounds.com/company/bekhealth) BEKhealth is an AI-powered clinical intelligence company that enhances electronic health record (EHR) data for clinical research. United States $9.0M
- [**OncoSynergy**](https://millionrounds.com/company/oncosynergy) OncoSynergy is a clinical-stage biotechnology startup focused on immuno-oncology, founded in 2011 and headquartered in Stamford, Connecticut. United States $6.6M
- [**ReNetX Bio**](https://millionrounds.com/company/renetx-bio) ReNetX Bio is a clinical-stage biotechnology company based in New Haven, Connecticut. United States $2.8M

### Series A

8 startups · $180M raised

- [**Azitra**](https://millionrounds.com/company/azitra) Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases. United States $49M
- [**Rallybio**](https://millionrounds.com/company/rallybio) Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease. United States $44M
- [**Alphina Therapeutics**](https://millionrounds.com/company/alphina-therapeutics) Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. United States $40M
- [**OOVA**](https://millionrounds.com/company/oova) Oova is a women's health and fertility technology company that specializes in at-home hormone monitoring. United States $11M
- [**Ancera**](https://millionrounds.com/company/ancera) Ancera is a technology company that specializes in software solutions for food production, focusing on enhancing security, efficie United States $10M
- [**Diameter Health**](https://millionrounds.com/company/diameter-health) Diameter Health is a software company that offers processing, predictive analytics, patient risk assessment, and data use. United States $9.8M
- [*TB* **Tangen Biosciences**](https://millionrounds.com/company/tangen-biosciences) Tangen Biosciences is a biotechnology company that offers molecular diagnostic technology services. United States $9.0M
- [**Affomix Corporation**](https://millionrounds.com/company/affomix-corporation) Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies. United States $7.0M

### Series B

7 startups · $354M raised

- [*HT* **Halda Therapeutics**](https://millionrounds.com/company/halda-therapeutics) Halda Therapeutics is a research-stage drug discovery company. United States $126M
- [**Normunity**](https://millionrounds.com/company/normunity) Normunity is a biotechnology company founded in 2020, focused on developing innovative precision immuno-oncology therapies. United States $75M
- [**Allyx Therapeutics**](https://millionrounds.com/company/allyx-therapeutics) Allyx Therapeutics is a clinical-stage biotechnology company based in New Haven, Connecticut, founded in 2019. United States $61M
- [**Cybrexa Therapeutics**](https://millionrounds.com/company/cybrexa-therapeutics) Cybrexa Therapeutics is a clinical-stage oncology biotechnology company based in New Haven, Connecticut, founded in 2017. United States $44M
- [**Simcha Therapeutics**](https://millionrounds.com/company/simcha-therapeutics) Simcha Therapeutics is a clinical-stage immunobiology company based in New Haven, Connecticut. United States $40M
- [**Bioarray Genetics**](https://millionrounds.com/company/bioarray-genetics) Bioarray Genetics is a molecular diagnostics and genetic testing company based in Farmington, Connecticut. United States $4.0M
- [**Precipio Diagnostics**](https://millionrounds.com/company/precipio-diagnostics) Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine. United States $3.4M

### Pre-seed and seed

3 startups · $19M raised

- [**Revalia Bio**](https://millionrounds.com/company/revalia-bio) Revalia Bio develops curative drugs for chronic organ-centered disease. United States $15M
- [*MB* **Modifi Bio**](https://millionrounds.com/company/modifi-bio) Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics. United States $4.3M
- [**Pattern Genomics**](https://millionrounds.com/company/pattern-genomics) Pattern Genomics develops Daydreamer, a software platform that enables simultaneous pattern analysis of DNA sequences and molecular assay. United States $150K

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Connecticut Innovations as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **Connecticut Innovations' Healthtech portfolio** 11 startups · $32M](https://millionrounds.com/portfolio-maps/connecticut-innovations-healthtech-portfolio)[Portfolio map **Connecticut Innovations portfolio map** 93 startups · $2.5B](https://millionrounds.com/portfolio-maps/connecticut-innovations-portfolio-map)[Co-investors **Who invests with Connecticut Innovations** 37 co-investors](https://millionrounds.com/portfolio-maps/connecticut-innovations-co-investors)[Sector portfolio **National Science Foundation's Biotech portfolio** 250 startups · $2.0B](https://millionrounds.com/portfolio-maps/nsf-small-business-innovation-research-small-business-techno-biotech-portfolio)[Sector portfolio **National Science Foundation's Healthtech portfolio** 149 startups · $516M](https://millionrounds.com/portfolio-maps/nsf-small-business-innovation-research-small-business-techno-healthtech-portfolio)[Sector portfolio **National Institutes of Health's Biotech portfolio** 145 startups · $2.5B](https://millionrounds.com/portfolio-maps/national-institutes-of-health-biotech-portfolio)

## Raising from investors like Connecticut Innovations?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
